Used in the synthesis of prostaglandin analogs, particularly in ophthalmic medications for treating glaucoma. It serves as a key chiral intermediate in the production of drugs that reduce intraocular pressure by enhancing uveoscleral outflow of aqueous humor. Its cyclopropyl structure with a hydroxymethyl group allows for selective biological activity and metabolic stability, making it valuable in developing long-acting ophthalmic therapeutics. Also employed in research for developing anti-inflammatory agents due to its structural similarity to bioactive lipid mediators.